Prof. Dr. Rauf Taner Divrik

Üroloji, Androloji

Hakkımda

Prof. Dr. Rauf Taner Divrik Ege Üniversitesi Tıp Fakültesi 'nden mezun olmuştur. SSK Tepecik Eğitim Hastanesi Üroloji Kliniğinde uzmanlık eğitimini tamamlayan , 2008 yılında doçent , 2014 yılında profesör olan Rauf Taner Divrik kendi özel muayenehanesinde hastalarına hizmet vermektedir.

Tümünü göster

Okullar / Eğitimler

Ege Üniversitesi Tıp Fakültesi
SSK Tepecik Eğitim Hastanesi Üroloji Kliniği Uzmanlık
Hacettepe Üniversitesi Tıp Fakültesi Üroonkoloji Eğitimi

Tümünü göster

Bilinen Diller

İngilizce

Tümünü göster

Sertifikalar

Tümünü göster

Ödüller

10.Üroonkoloji Kongresi, Üroonkoloji 2011 Araştırma Ödülü (26-30 Ekim 2011, Belek-Antalya)
20. Ulusal Üroloji Kongresi, Klinik Çalışmalar dalında en iyi bildiri (2008)
S.B. Tepecik Eğitim ve Araştırma Hastanesi Bireysel Bilimsel Performans Ödülü (2007)
8. Ankara Üroonkoloji Kursu, Üroonkoloji 2007 Araştırma Ödülü (2007)
S.B. Tepecik Eğitim ve Araştırma Hastanesi Bireysel Bilimsel Performans Ödülü (2006)
S.B. Tepecik Eğitim ve Araştırma Hst., “Ayın Başarılı Personeli” (Kasım 2005)
7. Ankara Üroonkoloji Kursu, Klinik Poster birinciliği (2005)
SSK Tepecik Eğitim Hastanesi, “Verimli ve üstün gayretli çalışan personel ödülü” (11.07.2001)
Üroloji Uzmanı S.B. Tepecik Eğitim ve Araştırma Hastanesi 2005-2013

Tümünü göster

Yayınlar

Divrik T, Yildirim Ü, Eroğlu A, Zorlu F, Özen H. Is a Second Transurethral Resection Necessary for Newly Diagnosed pT1 Bladder Cancer? J Urol. 2006 Apr; 175(4): 1258–1261.
Divrik RT, Yildirim Ü, Zorlu F, Özen H. The Effect of Repeat Transurethral Resection on Recurrence and Progression Rates in Patients With T1 Tumors of the Bladder Who Received Intravesical Mitomycin: A Prospective, Randomized Clinical Trial. J Urol. 2006 May; 175(5): 1641–1644.
Divrik RT, Akdoğan B, Özen H, Zorlu F. Outcomes of Surveillance Protocol of Clinical Stage I Nonseminomatous Germ Cell Tumors—Is Shift to Risk Adapted Policy Justified? J Urol. 2006; 176(4): 1424–1430.
Divrik RT, Eroğlu A, Şahin A, Zorlu F, Özen H. Increasing the number of biopsies increases the concordance of Gleason scores of needle biopsies and prostatectomy specimens. Urol Oncol. 2007;25: 376-382
Akdogan B, Divrik RT, Tombul T, Yazici S, Tasar C, Zorlu F, Ozen H. Bilateral Testicular Germ Cell Tumors in Turkey: Increase in incidence in last decade and evaluation of risk factors in 30 patients. J Urol. 2007; 178(1):129-133.
Divrik RT, Şahin A, Altok M, Ünlü N and Zorlu F. The Frequency of Hydronephrosis at Initial Diagnosis and Its Effect on Recurrence and Progression in Patients with Superficial Bladder Cancer. J Urol. 2007;178(3):802–806.
Eser S, Zorlu F, Divrik RT, Çag Ç, Özkan M, Kirkali Z. Incidence and Epidemiological Features of Cancer of the Genitourinary Tract in Izmir between 1993-2002. Asian Pacific J Cancer Prev. 2009;10;491-496.
Divrik RT, Şahin AF, Yildirim Ü, Altok M, Zorlu F. Impact of Routine Second Transurethral Resection on the Long-Term Outcome of Patients with Newly Diagnosed pT1 Urothelial Carcinoma with Respect to Recurrence, Progression Rate, and Disease-Specific Survival: A Prospective Randomised Clinical Trial. Eur Urol. 2010 Aug; 58(2): 185-190.
Divrik RT, Şahin AF, Ergör G. Reply from Authors re: Marko Babjuk. Second resection for non-muscle-invasive bladder carcinoma: Current role and future perspectives (Eur Urol 2010;58:191-2) and Giacomo Novara, Vincenzo Ficarra. Does routine second transurethral resection affect the long-term outcome of patients with t1 bladder cancer? why a flawed randomized controlled trial cannot address the issue (Eur Urol 2010;58:193-4). Eur Urol. 2010;58(2):195-96.
Tarhan H, Divrik RT, Akarken I, Altok M, Zorlu F. Benign Intrascrotal Lesion: Fibrous Pseudotumor of Testis. Arch Ital Urol. 2011;83(2):105-107.
Koc G, Divrik TR, Unlu N, Bulut V, Zorlu F. Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up? Int Urol Nephrol. 2011;43:1095-1100
Tarhan F, Tarhan H, Karaoğullarından U, Can E, Divrik T, Zorlu F. Premature ejaculation in patients with ankylosing spondylitis. Int J Androl. 2012 Feb;35(1):74-78.
Divrik RT, Türkeri L, Sahin AF, Akdoğan B, Ateş F, Cal C, Baltacı S. Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer. Urol Int. 2012 Jan;88(1):25-33
Divrik RT, Şahin FA. (Letter to the Editor) Re: Maurizio A. Brausi. Challenging the EAU Guidelines Regarding Early Repeat Transurethral Resection. Eur Urol Suppl 2011;10:e5–7. Eur Urol. 2012;62:e21-e22.
Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A Preoperative Prognostic Model Predicting Recurrence-free Survival for Patients With Kidney Cancer. Jpn J Clin Oncol. 2013 Jan;43(1):63-68
Tekgül ZT, Divrik RT, Turan M, Konyalıoğlu E et al. Impact of Obturator Nerve Block on the Short-Term Recurrence of Superficial Bladder Tumors on the Lateral Wall. Urology Journal. 2014 Jan-Feb;11(1): 1248-1252
Umul M. Altok M, Güneş M, Şahin A, Divrik T. Distal Ureteral Stricture: A Unexpected Complication Of Further Adjuvant Intravesical Mitomycin C Thermotherapy. CUAJ. 2014;8: 5-6.
Zorlu F, Divrik RT, Eser S, Yorukoglu K. Prostate Cancer Incidence in Turkey: An Epidemiological Study. Asian Pac J Cancer Prev. 2014; 15 (21), 9125-9130.(DOI: 10.7314/APJCP )
Kucuk U, Pala EE, Pala HG, Cakır E, Divrik RT. Tumor Mimicking Bladder Endometriosis. Medscidiscovery. 2015 Feb;2 (1): 161-164 (ISSN: 2148 – 6832)
Kucuk U, Pala EE, Cakır E, Sezer Or, Bayol U, Divrik RT, Cakmak O. Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder. Cent European J Urol. 2015; 68: 30-36. doi: 10.5173/ceju
Ekin RG, Akarken I, Cakmak O, Tarhan H, Celik O, Ilbey YO, Divrik RT, Zorlu F. Results of Intravesical Chemo-Hyperthermia in High-risk Non-muscle Invasive Bladder Cancer. Asian Pac J Cancer Prev. 2015;16(8):3241-5.
Kucuk U, Pala EE, Sezer O, Cakir E, Bayol U, Divrik RT. Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma. Acta Chir Belg. 2015; 115, 202-207. Journal ISSN: 0001-5458 (MedSci index)
Ekin RG, Akarken I, Zorlu F, Tarhan H, Kucuk U, Yildirim Z, Divrik RT. Intravesical bacillus Calmette-Guérin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer. Can Urol Assoc J. 2015 May-Jun; 9(5-6): E278-83. doi: 10.5489/cuaj.2708.
Altok M, Şahin AF, Divrik RT, Yildirim Ü, Zorlu F. Prospective comparison of ligation and bipolar cautery technique in non-scalpel vasectomy. Int Braz J Urol. Nov-Dec. 2015; 41(6): 1172-7 (doi: 5538. IBJU.2014.0356)
Bulut V, Şahin AF, Balaban Y, Altok M, Divrik RT, Zorlu F. The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy. Int Braz J Urol. Sep-Oct. 2015; 41 (5): 906-910 (doi: 5538. IBJU.2014.0419.)
Ün S, Türk H, Karabıçak M, Divrik RT, Zorlu F. Is a second look necessary in multiple and/or large Ta tumors? Arch Ital Urol Androl. 2016 Jul 4; 88(2): 86-88. DOI: 10.4081/aiua.2016.2.86 pISSN: 1124-3562 eISSN: 2282-4197
Şahin AF, Altok M, Akdeniz F, Yıldız G, Divrik RT. Second primary cancers in patients with urothelial cancers. Investig Clin Urol. 2016 Sep;57(5):330-5. doi: 10.4111/icu pISSN 2466-0493 • eISSN 2466-054X
Altok M, Sahin AF, Gokce MI, Ekin GR, Divrik RT. Ureteral orifice involvement by urothelial carcinoma: long term oncologic and functional outcomes. Int Braz J Urol. Nov-Dec. 2017; 43 (6): 1052-1059 (doi: 5538)
Tarhan H, Divrik RT, Akarken I, Altok M, Zorlu F. Benign Intrascrotal Lesion: Fibrous Pseudotumor of Testis. Arch Ital Urol. 2011;83(2):105-107.
Koc G, Divrik TR, Unlu N, Bulut V, Zorlu F. Does cisplatin-based chemotherapy effect on blood lipid levels of patients with germ cell testicular tumor in long-term follow-up? Int Urol Nephrol. 2011;43:1095-1100.
Tarhan F, Tarhan H, Karaoğullarından U, Can E, Divrik T, Zorlu F. Premature ejaculation in patients with ankylosing spondylitis. Int J Androl. 2012 Feb;35(1):74-78.
Divrik RT, Türkeri L, Sahin AF, Akdoğan B, Ateş F, Cal C, Baltacı S. Prediction of Response to Androgen Deprivation Therapy and Castration Resistance in Primary Metastatic Prostate Cancer. Urol Int. 2012 Jan;88(1):25-33
Divrik RT, Şahin FA. (Letter to the Editor) Re: Maurizio A. Brausi. Challenging the EAU Guidelines Regarding Early Repeat Transurethral Resection. Eur Urol Suppl 2011;10:e5–7. Eur Urol. 2012;62:e21-e22.
Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Ozen H; Society of Urooncology Study Group for Kidney Cancer Prognosis. A Preoperative Prognostic Model Predicting Recurrence-free Survival for Patients With Kidney Cancer. Jpn J Clin Oncol. 2013 Jan;43(1):63-68.
Tekgül ZT, Divrik RT, Turan M, Konyalıoğlu E et al. Impact of Obturator Nerve Block on the Short-Term Recurrence of Superficial Bladder Tumors on the Lateral Wall. Urology Journal. 2014 Jan-Feb;11(1): 1248-1252.
Umul M. Altok M, Güneş M, Şahin A, Divrik T. Distal Ureteral Stricture: A Unexpected Complication Of Further Adjuvant Intravesical Mitomycin C Thermotherapy. CUAJ. 2014;8: 5-6.
Zorlu F, Divrik RT, Eser S, Yorukoglu K. Prostate Cancer Incidence in Turkey: An Epidemiological Study. Asian Pac J Cancer Prev. 2014; 15 (21), 9125-9130.(DOI: 10.7314/APJCP )
Kucuk U, Pala EE, Pala HG, Cakır E, Divrik RT. Tumor Mimicking Bladder Endometriosis. Medscidiscovery. 2015 Feb;2 (1): 161-164 (ISSN: 2148 – 6832)
Kucuk U, Pala EE, Cakır E, Sezer Or, Bayol U, Divrik RT, Cakmak O. Clinical, demographic and histopathological prognostic factors for urothelial carcinoma of the bladder. Cent European J Urol. 2015; 68: 30-36. doi: 10.5173/ceju
Ekin RG, Akarken I, Cakmak O, Tarhan H, Celik O, Ilbey YO, Divrik RT, Zorlu F. Results of Intravesical Chemo-Hyperthermia in High-risk Non-muscle Invasive Bladder Cancer. Asian Pac J Cancer Prev. 2015;16(8):3241-5.
Kucuk U, Pala EE, Sezer O, Cakir E, Bayol U, Divrik RT. Significance of TNM staging, Demographic and Histologic Features in Predicting the Prognosis of Renal Cell Carcinoma. Acta Chir Belg. 2015; 115, 202-207. Journal ISSN: 0001-5458 (MedSci index)
Ekin RG, Akarken I, Zorlu F, Tarhan H, Kucuk U, Yildirim Z, Divrik RT. Intravesical bacillus Calmette-Guérin versus chemohyperthermia for high-risk non-muscle-invasive bladder cancer. Can Urol Assoc J. 2015 May-Jun; 9(5-6): E278-83. doi: 10.5489/cuaj.2708.
Altok M, Şahin AF, Divrik RT, Yildirim Ü, Zorlu F. Prospective comparison of ligation and bipolar cautery technique in non-scalpel vasectomy. Int Braz J Urol. Nov-Dec. 2015; 41(6): 1172-7 (doi: 5538. IBJU.2014.0356)
Bulut V, Şahin AF, Balaban Y, Altok M, Divrik RT, Zorlu F. The efficacy of duration of prophylactic antibiotics in transrectal ultrasound guided prostate biopsy. Int Braz J Urol. Sep-Oct. 2015; 41 (5): 906-910 (doi: 5538. IBJU.2014.0419.)
Ün S, Türk H, Karabıçak M, Divrik RT, Zorlu F. Is a second look necessary in multiple and/or large Ta tumors? Arch Ital Urol Androl. 2016 Jul 4; 88(2): 86-88. DOI: 10.4081/aiua.2016.2.86 pISSN: 1124-3562 eISSN: 2282-4197
Şahin AF, Altok M, Akdeniz F, Yıldız G, Divrik RT. Second primary cancers in patients with urothelial cancers. Investig Clin Urol. 2016 Sep;57(5):330-5. doi: 10.4111/icu pISSN 2466-0493 • eISSN 2466-054X
Altok M, Sahin AF, Gokce MI, Ekin GR, Divrik RT. Ureteral orifice involvement by urothelial carcinoma: long term oncologic and functional outcomes. Int Braz J Urol. Nov-Dec. 2017; 43 (6): 1052-1059 (doi: 5538)
Zorlu F, Divrik T, Mertoğlu O. “Can We Diagnose Renal Oncocytoma by CT findings?” 5th. Mediterranean Congress of Urology, Barcelona-Spain, Abstract Book, A2 (1997).
Zorlu F, Mertoğlu O, Divrik T. “The factors affecting quality of life in patients with benign prostate hyperplasia.” 5th. Mediterranean Congress of Urology, Barcelona-Spain, Abstract Book, A16 (1997).
Kaçar S, Yıldırım Ü, Divrik T, Zorlu F, “Retroperitoneal and transperitoneal nephrectomy in benign kidney diease.” 3th Mediterranean & Middle Eastern Endoscopic Surgery Congress, İstanbul, Abstract Book, 58 (2003
Akdogan B, Divrik T, Dogan S, Tombul T, Zorlu F, Tasar C, Ozen H. “Bilateral Testicular Germ cell Tumours in Turkey: Long-term results and risk factors in 27 patients.” Eur Urol Suppl, 5(2): 88 (2006).
Divrik RT, Akdogan B, Ozen H, Zorlu F. “Outcomes of Surveillance Protocol of Clinical Stage 1 Non-seminomatous Germ cell tumours: Is shift to risk-adapted policy justified?” Eur Urol Suppl, 5(2): 97 (2006).
Şahin AF, Bulut V, Akgül K, Divrik RT, Zorlu F. “Late Effects of Testicular Tumor Therapies on Erectile Function.” J Sex Med. 2008;UP-183, pg.131. 13th World Congress of the ISSM-11th Congress of the ESSM, 7-11 Dec. 2008 Brussels-Belgium
Yaycioglu O, Eskicorapci S, Karabulut E, Soyupak B, Gogus C, Divrik T, Turkeri L, Yazici S, Turkish Study Group For Kidney Cancer Prognosis, Ozen H. A Preoperative Prognostic Model Predicting Recurrence Free Survival For Patients With Kidney Cancer: A Multi-Center Study By The Society Of Urooncology. AUA 2011, A-527.
Koc G, Divrik T, Unlu N, Bulut V, Zorlu F. Does Cisplatin-based Chemotherapy Effect on Blood Lipid Levels of Patients with Germ Cell Testicular Tumor in Long Term Follow-Up? 31st Congress of SIU (October 16-202011, Berlin). Urology. 2011 Sep;78 (Supp 3A):S379 (UP-03.110)
Divrik RT, Türkeri L, Sahin AF, Akdoğan B, Ateş F, Çal Ç, Baltacı S. Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer. EMUC 2012, P121. Eur Urol. 2012; Supl. 11: 233
Altok M, Şahin AF, Ün S, Koca O, Divrik RT. The Association Between Resection Of Bladder Cancers Around Ureteral Orifices And Upper Tract Urothelial Cancers. AUA Annual Meeting New Orleans, USA, 2015. J Urol. Vol.193, 4S (Suppl)page e71-e72 (MP7-20)